Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.

[1]  C. Lemière,et al.  Increased glucocorticoid receptor-beta expression, but not decreased histone deacetylase 2, in severe asthma. , 2006, The Journal of allergy and clinical immunology.

[2]  L. Boulet,et al.  Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations , 2006, European Respiratory Journal.

[3]  S. Wenzel,et al.  Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. , 2005, The Journal of allergy and clinical immunology.

[4]  I. Pavord,et al.  The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  J. Cowan,et al.  Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.

[6]  A. Zwinderman,et al.  "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. , 2004, American journal of respiratory and critical care medicine.

[7]  P. Paggiaro,et al.  Clinical assessment of asthma severity partially corresponds to sputum eosinophilic airway inflammation , 2004 .

[8]  A. Woodcock,et al.  Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  J. Bousquet,et al.  Eosinophilic inflammation in sputum of poorly controlled asthmatics , 2002, European Respiratory Journal.

[10]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[11]  C. Salome,et al.  Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms , 2002, Thorax.

[12]  L. Boulet,et al.  Bronchial inflammation in corticosteroid‐sensitive and corticosteroid‐resistant asthma at baseline and on oral corticosteroid treatment , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  A. Zwinderman,et al.  Factors associated with persistent airflow limitation in severe asthma. , 2001, American journal of respiratory and critical care medicine.

[14]  P. Barnes,et al.  Clinical aspects of exhaled nitric oxide. , 2000, The European respiratory journal.

[15]  E. Juniper,et al.  Measuring asthma control. Clinic questionnaire or daily diary? , 2000, American journal of respiratory and critical care medicine.

[16]  M. Sears,et al.  Induced sputum cell counts: their usefulness in clinical practice. , 2000, The European respiratory journal.

[17]  A. Jang,et al.  Immunohistochemically Stained Activated Eosinophils in Sputum in Patients with Asthma , 2000, Respiration.

[18]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[19]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[20]  J. Fahy,et al.  Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. , 1999, The Journal of allergy and clinical immunology.

[21]  I. Pavord,et al.  Non-eosinophilic cor ticosteroid unresponsive asthma , 1999, The Lancet.

[22]  T. Platts-Mills,et al.  Expired nitric oxide and airway obstruction in asthma patients with an acute exacerbation. , 1999, American journal of respiratory and critical care medicine.

[23]  F. Hargreave.  Induced sputum and response to glucocorticoids. , 1998, The Journal of allergy and clinical immunology.

[24]  S. Wenzel,et al.  Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. , 1997, American journal of respiratory and critical care medicine.

[25]  P. Sterk,et al.  Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[26]  F. Hargreave,et al.  Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. , 1997, American journal of respiratory and critical care medicine.

[27]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[28]  F. Hargreave,et al.  Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. , 1996, The European respiratory journal.

[29]  L. Fabbri,et al.  Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. , 1995, American journal of respiratory and critical care medicine.

[30]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[31]  J. Stamler,et al.  Expired nitric oxide levels during treatment of acute asthma. , 1995, American journal of respiratory and critical care medicine.

[32]  H. Boushey,et al.  Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. , 1994, The Journal of allergy and clinical immunology.

[33]  P. O'Byrne,et al.  Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses. , 1992, The American review of respiratory disease.

[34]  P. O'Byrne,et al.  Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. , 1992, The American review of respiratory disease.

[35]  G. Guyatt,et al.  A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[36]  J. Denburg,et al.  Use of induced sputum cell counts to investigate airway inflammation in asthma. , 1992, Thorax.